Collington, Rosie; Lazonick, William - 2022
approved medicines to patients. We introduce a regulatory approach we term “Pricing for Medicine Innovation” (PMI), which … with this pricing approach. Firstly, in an innovation system where a company’s sales revenue is the source of its finance … for further drug development, price caps may deprive a firm of the means to invest in innovation. Secondly, even with …